-
JSPR Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Jasper Therapeutics (JSPR)
Company Profile
Quarter (USD) | Sep 24 | Mar 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 92.92 mm | 92.92 mm | 92.92 mm | 92.92 mm | 92.92 mm | |
Cash burn (monthly) | 8.66 mm | 1.94 mm | 6.63 mm | 6.00 mm | 3.68 mm | |
Cash used (since last report) | 24.23 mm | 5.44 mm | 18.56 mm | 16.80 mm | 10.31 mm | |
Cash remaining | 68.69 mm | 87.48 mm | 74.36 mm | 76.11 mm | 82.61 mm | |
Runway (months of cash) | 7.9 | 45.0 | 11.2 | 12.7 | 22.4 |
13F holders | Current |
---|---|
Total holders | 48 |
Opened positions | 24 |
Closed positions | 27 |
Increased positions | 7 |
Reduced positions | 4 |
13F shares | Current |
---|---|
Total value | 229.29 bn |
Total shares | 42.13 mm |
Total puts | 32.70 k |
Total calls | 140.70 k |
Total put/call ratio | 0.2 |
Largest owners | Shares | Value |
---|---|---|
Biotechnology Value Fund L P | 9.90 mm | $18.32 mm |
Soleus Capital Master Fund | 6.25 mm | $10.88 mm |
Qiming U.S. Healthcare Fund II | 5.85 mm | $88.50 mm |
Roche Finance | 4.62 mm | $0.00 |
Avego Management | 2.84 mm | $0.00 |
Amplitude Healthcare | 1.50 mm | $4.41 mm |
Velan Capital Investment Management | 1.47 mm | $32.55 bn |
Soleus Capital Management | 1.28 mm | $28.97 bn |
AMGN Amgen | 1.01 mm | $1.72 mm |
Avidity Partners Management | 782.00 k | $17.75 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
12 Dec 24 | Jeetinder Singh Mahal | Voting Common Stock | Sell | Dispose S | No | Yes | 22.11 | 900 | 19.90 k | 25,009 |
12 Dec 24 | Jeetinder Singh Mahal | Voting Common Stock | Option exercise | Acquire M | No | Yes | 7.1 | 900 | 6.39 k | 25,909 |
12 Dec 24 | Jeetinder Singh Mahal | Stock Option Voting Common Stock | Option exercise | Acquire M | No | Yes | 7.1 | 900 | 6.39 k | 13,772 |
12 Sep 24 | Jeetinder Singh Mahal | Voting Common Stock | Sell | Dispose S | No | Yes | 21.2263 | 900 | 19.10 k | 25,009 |
12 Sep 24 | Jeetinder Singh Mahal | Voting Common Stock | Option exercise | Acquire M | No | Yes | 7.1 | 900 | 6.39 k | 25,909 |
12 Sep 24 | Jeetinder Singh Mahal | Stock Option Voting Common Stock | Option exercise | Acquire M | No | Yes | 7.1 | 900 | 6.39 k | 14,672 |
18 Jun 24 | Lucas Svetlana | Stock Option Voting Common Stock | Grant | Acquire A | No | No | 23.19 | 15,000 | 347.85 k | 15,000 |
12 Jun 24 | Jeetinder Singh Mahal | Voting Common Stock | Sell | Dispose S | No | Yes | 24.155 | 900 | 21.74 k | 25,009 |
12 Jun 24 | Jeetinder Singh Mahal | Voting Common Stock | Option exercise | Acquire M | No | Yes | 7.1 | 900 | 6.39 k | 25,909 |
12 Jun 24 | Jeetinder Singh Mahal | Stock Option Voting Common Stock | Option exercise | Acquire M | No | Yes | 7.1 | 900 | 6.39 k | 15,572 |